Cardiovascular Disease With Androgen Deprivation: The (forgotten) Role of Testosterone

被引：1
作者：
Aragon-Ching, Jeanny B. [1 ]
机构：
[1] George Washington Univ, Med Ctr, Washington, DC 20037 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 35期
关键词：
ADVANCED PROSTATE-CANCER; THERAPY; MORTALITY; RISK;
D O I：
10.1200/JCO.2009.25.4078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E261 / E261
页数：1
相关论文
共 10 条
  • [1] Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
    Alibhai, Shabbir M. H.
    Duong-Hua, Minh
    Sutradhar, Rinku
    Fleshner, Neil E.
    Warde, Padraig
    Cheung, Angela M.
    Paszat, Lawrence F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) : 3452 - 3458
  • [2] Centers for Disease Control, 2004, LEAD CAUS DEATH AG G
  • [3] Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions
    D'Amico, Anthony V.
    Denham, James W.
    Crook, Juanita
    Chen, Ming-Hui
    Goldhaber, Samuel Z.
    Lamb, David S.
    Joseph, David
    Tai, Keen-Hun
    Malone, Shawn
    Ludgate, Charles
    Steigler, Allison
    Kantoff, Philip W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (17) : 2420 - 2425
  • [4] Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
    Efstathiou, Jason A.
    Bae, Kyounghwa
    Shipley, William U.
    Hanks, Gerald E.
    Pilepich, Miljenko V.
    Sandler, Howard M.
    Smith, Matthew R.
    [J]. EUROPEAN UROLOGY, 2008, 54 (04) : 816 - 824
  • [5] Cardiovascular Mortality After Androgen Deprivation Therapy for Locally Advanced Prostate Cancer: RTOG 85-31
    Efstathiou, Jason A.
    Bae, Kyounghwa
    Shipley, William U.
    Hanks, Gerald E.
    Pilepich, Miljenko V.
    Sandler, Howard M.
    Smith, Matthew R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (01) : 92 - 99
  • [6] Kinetics of serum androgen normalization and factors associated with testosterone reserve after limited androgen deprivation therapy for nonmetastatic prostate cancer
    Gulley, James L.
    Aragon-Ching, Jeanny B.
    Steinberg, Seth M.
    Hussain, Maha H.
    Sartor, Oliver
    Higano, Celestia S.
    Petrylak, Daniel P.
    Chatta, Gurkamal S.
    Arlen, Philip M.
    Figg, William D.
    Dahut, William L.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (04) : 1432 - 1437
  • [7] Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study
    Khaw, Kay-Tee
    Dowsett, Mitch
    Folkerd, Elizabeth
    Bingham, Sheila
    Wareham, Nicholas
    Luben, Robert
    Welch, Ailsa
    Day, Nicholas
    [J]. CIRCULATION, 2007, 116 (23) : 2694 - 2701
  • [8] Sex hormones as novel risk biomarkers for atherosclerosis in peripheral vascular disease
    Liu, Peter P.
    Fukuoka, Masahiro
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (11) : 1077 - 1079
  • [9] Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610
    Roach, Mack, III
    Bae, Kyounghwa
    Speight, Joycelyn
    Wolkov, Harvey B.
    Rubin, Phillip
    Lee, R. Jeffrey
    Lawton, Colleen
    Valicenti, Richard
    Grignon, David
    Pilepich, Miljenko V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) : 585 - 591
  • [10] Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality
    Tsai, Henry K.
    D'Annico, Anthony V.
    Sadetsky, Natalia
    Chen, Ming-Hui
    Carroll, Peter R.
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (20) : 1516 - 1524
1